GILD

Gilead Sciences Inc

May 18 • 02:29PM ET

130.26

+0.68 0.52 %

Healthcare • Drug Manufacturers - General • USA • Large • NASD

Peers: BMY PFE ABBV MRK AZN NVS LLY SNY AMGN TAK

| Held by: VTI VOO QQQ IVV SPY VTV XLV VIG QQQM VYM

Scroll to Statements

Index	NDX, S&P 500	P/E	17.72	EPS (ttm)	7.35	Insider Own	0.15%	Shs Outstand	1.24B	Perf Week	-2.44%
Market Cap	161.73B	Forward P/E	13.53	EPS next Y	9.63	Insider Trans	-17.40%	Shs Float	1.24B	Perf Month	-5.36%
Enterprise Value	174.00B	PEG	1.52	EPS next Q	-6.60	Inst Own	89.01%	Short Float	1.86%	Perf Quarter	-16.11%
Income	9.22B	P/S	5.43	EPS this Y	-92.52%	Inst Trans	-0.18%	Short Ratio	3.73	Perf Half Y	4.04%
Sales	29.79B	P/B	6.88	EPS next Y	1479.03%	ROA	16.35%	Short Interest	23.05M	Perf YTD	6.13%
Book/sh	18.93	P/C	16.47	EPS next 5Y	8.93%	ROE	43.19%	52W High	157.29 -17.18%	Perf Year	27.08%
Cash/sh	7.91	P/FCF	15.81	EPS past 3/5Y	23.06% 133.64%	ROIC	20.77%	52W Low	100.23 29.96%	Perf 3Y	66.55%
Dividend Est.	3.25 (2.49%)	EV/EBITDA	11.78	Sales past 3/5Y	2.83% 3.63%	Gross Margin	79.41%	Volatility	2.80% 2.42%	Perf 5Y	89.19%
Dividend TTM	3.19 (2.45%)	EV/Sales	5.84	EPS Y/Y TTM	55.01%	Oper. Margin	40.41%	ATR (14)	3.24	Perf 10Y	57.17%
Dividend Ex-Date	Jun 15, 2026	Quick Ratio	1.77	Sales Y/Y TTM	3.83%	Profit Margin	30.94%	RSI (14)	41.43	Recom	1.66
Dividend Gr. 3/5Y	2.67% 3.04%	Current Ratio	1.97	EPS Q/Q	54.29%	SMA20	-1.31%	Beta	0.33	Target Price	160.56
Payout	46.60%	Debt/Eq	0.94	Sales Q/Q	5.09%	SMA50	-4.97%	Rel Volume	0.59	Prev Close	129.58
Employees	17000	LT Debt/Eq	0.89	Earnings	May 07 AMC	SMA200	1.81%	Avg Volume	6.18M	Price	130.26
IPO	Jan 22, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.31% 0.67%	Trades		Volume	2,837,391	Change	0.52%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)